Who owns Novozymes A/s Unspons Adr adr?
- Ticker: NVZMY
- CUSIP Number: 670108109
Tip: Access positions for across all investors
Analyze quarterly positions in Novozymes A/s Unspons with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Novozymes A/s Unspons stock
Who bought or sold Novozymes A/s Unspons Adr adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rhumbline Advisers | 10k | $637k | -2% | Dec 2025 |
|
| Sterling Capital Management | 5.3k | $343k | -17% | Dec 2025 |
|
| S & Co | 4.5k | $288k | 0% | Dec 2025 |
|
| Pnc Financial Services | 1.6k | $99k | -2% | Dec 2025 |
|
| GAMMA Investing | 1.5k | $90k | -33% | Mar 2026 |
|
| Salomon & Ludwin | 237.00 | $15k | 27% | Dec 2025 |
|
| Ancora Advisors | 157.00 | $10k | 100% | Dec 2025 |
|
| Copeland Capital Management | 49.00 | $3.1k | 0% | Dec 2025 |
|
| TrueNorth | 15.00 | $954.000000 | 100% | Dec 2025 |
|
| Ameriflex Group | 14.00 | $891.000600 | -50% | Dec 2025 |
|
Who sold out of Novozymes A/s Unspons?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boston Common Asset Management | Sep 2025 | 4.6k | $283k |